A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder
Herschorn, Sender, Barkin, Jack, Castro-Diaz, David, Frankel, Jeffrey M., Espuna-Pons, Montserrat, Gousse, Angelo E., Stölzel, Matthias, Martin, Nancy, Gunther, Adrie, Van Kerrebroeck, PhilipVolume:
82
Language:
english
Journal:
Urology
DOI:
10.1016/j.urology.2013.02.077
Date:
August, 2013
File:
PDF, 407 KB
english, 2013